Darou Pakhsh Pharma Chem
Darou Pakhsh Pharma Chem (DPPC) is an Iran-based public manufacturer of Active Pharmaceutical Ingredients, pellet products, and sterile injectable APIs. Listed on the Tehran Stock Exchange under TIPICO Pharmaceutical Holding, it serves domestic and export pharmaceutical markets.
- Company typePublic
- Founded1996
- HeadquartersTaleghan, Iran
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Darou Pakhsh Pharma Chem firmographics
Firmographics- Name
- Darou Pakhsh Pharma Chem
- Legal name
- Daroupakhsh Pharmaceutical Chemical Company (شرکت شیمی دارویی داروپخش)
- Website
- https://dppcco.com
- Company type
- Public
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Darou Pakhsh Pharma Chem (DPPC) is an Iran-based public manufacturer of Active Pharmaceutical Ingredients, pellet products, and sterile injectable APIs. Listed on the Tehran Stock Exchange under TIPICO Pharmaceutical Holding, it serves domestic and export pharmaceutical markets.
- Ownership category
- akta.pro rank
Darou Pakhsh Pharma Chem industry classification
Industry- Product category
- Active Pharmaceutical Ingredients
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Small-Molecule API Commercial Manufacturing (HLAGAHAB)
- akta.pro secondary industries
- Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where Darou Pakhsh Pharma Chem is headquartered
LocationHeadquarters
- HQ city
- Taleghan
- HQ country
- Iran
- HQ region
- Middle East
Offices2 records
Markets served
Darou Pakhsh Pharma Chem business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Active Pharmaceutical Ingredient (API) Sales: Manufacture and sale of pharmaceutical raw materials including general APIs, LVHV APIs, injectable-grade APIs, and pellet products to domestic pharmaceutical companies and export markets.
- Toll Manufacturing (Commissioned Production): Contract/toll manufacturing services producing APIs and semi-finished pharmaceutical materials for other companies within the TIPICO group and external clients.
- R&D and Development Services: Development of new API products with registered 26 knowledge-based products and 14 R&D projects valued at 25 billion Tomans entered tax credit evaluation phase.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Darou Pakhsh Pharma Chem product offering
Product offeringCore offering
Darou Pakhsh Pharma Chem manufactures and sells Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry. The company produces general APIs, Low Volume High Value (LVHV) APIs, injectable-grade sterile APIs, and pharmaceutical pellet products for controlled-release formulations, supplying both domestic Iranian pharmaceutical manufacturers and export markets through GMP-certified production facilities.
Product overview
Darou Pakhsh Pharma Chem operates as a pharmaceutical manufacturer producing Active Pharmaceutical Ingredients (APIs) organized into four main product lines: API-General (general-purpose APIs across cardiovascular, anti-inflammatory, antibiotic, gastrointestinal, and neurological therapeutic categories), Pellet Products (controlled-release pharmaceutical pellets), API-LVHV (high-value low-volume specialized APIs), and API-Injectable (sterile-grade APIs for injectable drug manufacturing). The company holds 82 production licenses and 26 knowledge-based products, positioning itself as one of Iran's most diversified API manufacturers with products spanning over 45 compounds including combination formulations of Clavulanate Potassium with Amoxicillin and microcrystalline cellulose.
Differentiator
Problem solved
Functional benefit
Products and services
- API-General General Active Pharmaceutical Ingredients covering cardiovascular, anti-inflammatory, antibiotic, gastrointestinal, neurological and psychiatric therapeutic categories including Atenolol, Azithromycin, Captopril, Diclofenac Sodium, and others.
- Pellet Products Pharmaceutical pellets for controlled and effective release of active ingredients, including Orlistat, Tamsulosin, Diclofenac Sodium, Duloxetine, and Fenofibrate in various concentrations.
- API-LVHV High-Value, Low-Volume Active Pharmaceutical Ingredients for specialized and specialty drugs including Repaglinide, Memantine, Donepezil, Solifenacin, and Varenicline.
- API Injectable Sterile Active Pharmaceutical Ingredients for manufacturing injectable drugs meeting global standards, including Granisetron Hydrochloride, Ondansetron Hydrochloride, Ketorolac Tromethamine, and others.
Quantifiable outcome
- 127% increase in net profit (from 822 to 1,866 billion Rials) in fiscal year 1404
- +3 more outcomes
Companies that use Darou Pakhsh Pharma Chem
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Darou Pakhsh Pharma Chem technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Darou Pakhsh Pharma Chem partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TIPICO Pharmaceutical Holding (شرکت سرمایهگذاری دارویی تأمین)coreTIPICO (Tamin Pharmaceutical Investment Company) is the parent pharmaceutical holding company under which Darou Pakhsh Pharma Chem operates as a subsidiary. The company is listed on the Tehran Stock Exchange and is an integral part of TIPICO's pharmaceutical value chain, contributing to the group's strategy of domestic API production and pharmaceutical self-sufficiency.
Scale indicators11 records
Recent moves8 records
Expansion highlights4 records
Darou Pakhsh Pharma Chem competitors and assessment
Company assessmentBroad incumbents
- Dr. Reddy's Laboratories: Integrated Indian pharmaceutical company with substantial API manufacturing operations and global formulations business. Comparable on API manufacturing scale, GMP certifications, and regulatory depth across multiple therapeutic categories.
- Cipla: Major Indian pharmaceutical manufacturer with significant API manufacturing capability spanning respiratory, anti-retroviral, and other therapeutic areas. Comparable on GMP-certified multi-site API production and international market reach.
- Teva Pharmaceutical Industries: Israel-headquartered global generic pharmaceutical leader with one of the world's largest API manufacturing footprints. Comparable on broad small-molecule API portfolio and GMP-certified multi-site manufacturing, though at much larger scale.
- Sun Pharmaceutical Industries: India's largest pharmaceutical company with extensive API and finished dosage form manufacturing. Comparable on diversified API portfolio, GMP-certified multi-site operations, and global export orientation.
- Aurobindo Pharma: Major India-headquartered generic pharmaceutical and API manufacturer with broad therapeutic coverage. Directly comparable as a large-scale, multi-product small-molecule API manufacturer targeting global markets, particularly relevant given DPPC's CPHI India export push.
Direct peers
- Natco Pharma: Indian pharmaceutical firm with API manufacturing capabilities and specialty focus on complex generics and oncology. Comparable on portfolio breadth across APIs and on GMP manufacturing depth in differentiated dosage-form categories.
- Laurus Labs: Indian API and formulations manufacturer with strong position in small-molecule APIs and ARV therapeutic categories. Comparable as a growing, knowledge-driven API manufacturer expanding into complex and specialty API categories.
- Divis Laboratories: India-based pure-play API manufacturer specializing in complex generics and active ingredients. Closely comparable business model as a focused, GMP-certified commercial API manufacturer with global export orientation.
- Ipca Laboratories: Indian pharmaceutical company focused on APIs and formulations with strong domestic and export presence. Comparable as a mid-sized API manufacturer with diversified therapeutic coverage and GMP-certified facilities.
- Hikal: India-based API and contract manufacturer serving global pharmaceutical companies. Comparable as a B2B API and CDMO provider with GMP-certified facilities and an export-oriented GTM motion.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Darou Pakhsh Pharma Chem social profiles
Digital presenceDarou Pakhsh Pharma Chem compliance and trust
Trust signalCompliance14 records
Darou Pakhsh Pharma Chem financial estimates
Financial estimateRevenue estimate
Valuation estimate
Darou Pakhsh Pharma Chem leadership team
Management profileNumber of profiles
Profiles12 records
Darou Pakhsh Pharma Chem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Darou Pakhsh Pharma Chem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Darou Pakhsh Pharma Chem
What does Darou Pakhsh Pharma Chem do?
Darou Pakhsh Pharma Chem manufactures and sells Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry. The company produces general APIs, Low Volume High Value (LVHV) APIs, injectable-grade sterile APIs, and pharmaceutical pellet products for controlled-release formulations, supplying both domestic Iranian pharmaceutical manufacturers and export markets through GMP-certified production facilities.
Is Darou Pakhsh Pharma Chem a public or private company?
Darou Pakhsh Pharma Chem is a public company. It is classified as public and is currently operating.
When was Darou Pakhsh Pharma Chem founded?
Darou Pakhsh Pharma Chem was founded in 1996. It employs 101 to 250 people.
Where is Darou Pakhsh Pharma Chem based?
Darou Pakhsh Pharma Chem is headquartered in Taleghan, Iran, in the Middle East region.
How does Darou Pakhsh Pharma Chem make money?
Three revenue lines are on record. Active Pharmaceutical Ingredient (API) Sales are the primary driver. The others are toll Manufacturing (Commissioned Production) and R&D and Development Services.
Who are Darou Pakhsh Pharma Chem's main competitors?
Broad incumbents on record are Dr. Reddy's Laboratories, Cipla, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries and Aurobindo Pharma. Direct peers are Natco Pharma, Laurus Labs, Divis Laboratories, Ipca Laboratories and Hikal.
Does Darou Pakhsh Pharma Chem have an API?
No public API is recorded for Darou Pakhsh Pharma Chem.
What industry is Darou Pakhsh Pharma Chem in?
Darou Pakhsh Pharma Chem's product category is Active Pharmaceutical Ingredients. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAIABAG, Generic APIs & Intermediates (Active Ingredients). Its NAICS code is 3254 and its SIC code is 2833.